Literature DB >> 16410534

Altered peptide ligands regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjögren's syndrome.

Y Naito1, I Matsumoto, E Wakamatsu, D Goto, S Ito, A Tsutsumi, T Sumida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16410534      PMCID： PMC1798016          DOI： 10.1136/ard.2005.039065

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

Review 1.  Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis.

Authors:  T P Gordon; A I Bolstad; M Rischmueller; R Jonsson; S A Waterman
Journal:  Autoimmunity       Date:  2001       Impact factor: 2.815

Review 2.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

3.  Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome.

Authors:  Y Naito; I Matsumoto; E Wakamatsu; D Goto; T Sugiyama; R Matsumura; S Ito; A Tsutsumi; T Sumida
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

4.  Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor.

Authors:  M T De Magistris; J Alexander; M Coggeshall; A Altman; F C Gaeta; H M Grey; A Sette
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

5.  Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity.

Authors:  Takashi Fujibayashi; Susumu Sugai; Nobuyuki Miyasaka; Yoshio Hayashi; Kazuo Tsubota
Journal:  Mod Rheumatol       Date:  2004-12       Impact factor: 3.023

Review 6.  T-cell receptor in Sjögren's syndrome.

Authors:  T Sumida; I Matsumoto; T Maeda; K Nishioka
Journal:  Br J Rheumatol       Date:  1997-06

7.  New T-cell epitope of Ro/SS-A 52 kDa protein in labial salivary glands from patients with Sjögren's syndrome.

Authors:  T Sumida; T Namekawa; T Maeda; K Nishioka
Journal:  Lancet       Date:  1996-12-14       Impact factor: 79.321

8.  Peripheral blood in Sjögren's syndrome does not contain increased levels of T lymphocytes reactive with the recombinant Ro/SS-A 52 kD and La/SS-B 48 kD autoantigens.

Authors:  A K Halse; M Wahren; R Jonsson
Journal:  Autoimmunity       Date:  1996       Impact factor: 2.815

9.  Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo.

Authors:  C Pfeiffer; J Stein; S Southwood; H Ketelaar; A Sette; K Bottomly
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307
  9 in total
  8 in total

1.  M3 muscarinic acetylcholine receptor-reactive Th17 cells in primary Sjögren's syndrome.

Authors:  Saori Abe; Hiroto Tsuboi; Hanae Kudo; Hiromitsu Asashima; Yuko Ono; Fumika Honda; Hiroyuki Takahashi; Mizuki Yagishita; Shinya Hagiwara; Yuya Kondo; Isao Matsumoto; Takayuki Sumida
Journal:  JCI Insight       Date:  2020-08-06

2.  RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.

Authors:  M Tahara; H Tsuboi; S Segawa; H Asashima; M Iizuka-Koga; T Hirota; H Takahashi; Y Kondo; M Matsui; I Matsumoto; T Sumida
Journal:  Clin Exp Immunol       Date:  2016-10-11       Impact factor: 4.330

3.  Muscarinic type 3 receptor autoantibodies are associated with anti-SSA/Ro autoantibodies in Sjögren's syndrome.

Authors:  Jian Zuo; Adrienne E G Williams; Yun-Jong Park; Kevin Choi; Annie L Chan; Westley H Reeves; Michael R Bubb; Yun Jong Lee; Kyungpyo Park; Carol M Stewart; Seunghee Cha
Journal:  J Immunol Methods       Date:  2016-07-25       Impact factor: 2.303

4.  Effects of muscarinic acetylcholine 3 receptor(208-227) peptide immunization on autoimmune response in nonobese diabetic mice.

Authors:  Lin Yang; Jinzhe Ju; Wei Zhang; Fengfeng Lv; Chunyan Pang; Guoan Yang; Yongfu Wang
Journal:  Clin Dev Immunol       Date:  2013-12-09

5.  Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.

Authors:  Joanna Kern; Robert Drutel; Silvia Leanhart; Marek Bogacz; Rafal Pacholczyk
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

6.  Functional Analysis of Dendritic Cells Generated from T-iPSCs from CD4+ T Cell Clones of Sjögren's Syndrome.

Authors:  Mana Iizuka-Koga; Hiromitsu Asashima; Miki Ando; Chen-Yi Lai; Shinji Mochizuki; Mahito Nakanishi; Toshinobu Nishimura; Hiroto Tsuboi; Tomoya Hirota; Hiroyuki Takahashi; Isao Matsumoto; Makoto Otsu; Takayuki Sumida
Journal:  Stem Cell Reports       Date:  2017-05-09       Impact factor: 7.765

7.  Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate isomerase peptide.

Authors:  Keiichi Iwanami; Isao Matsumoto; Yohei Yoshiga; Asuka Inoue; Yuya Kondo; Kayo Yamamoto; Yoko Tanaka; Reiko Minami; Taichi Hayashi; Daisuke Goto; Satoshi Ito; Yasuharu Nishimura; Takayuki Sumida
Journal:  Arthritis Res Ther       Date:  2009-11-09       Impact factor: 5.156

Review 8.  Role of the Innate Immunity Signaling Pathway in the Pathogenesis of Sjögren's Syndrome.

Authors:  Toshimasa Shimizu; Hideki Nakamura; Atsushi Kawakami
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.